ReviewFrontiers in cellular and infection microbiology2021

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against

Ahmed Gamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.